NUVA Share Price

Open 69.66 Change Price %
High 70.96 1 Day 0.30 0.43
Low 69.66 1 Week -0.06 -0.09
Close 70.29 1 Month 4.00 6.03
Volume 557709 1 Year 23.52 50.29
52 Week High 71.03
52 Week Low 36.81
NUVA Important Levels
Resistance 2 71.50
Resistance 1 71.00
Pivot 70.30
Support 1 69.58
Support 2 69.08
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
DRYS 1.01 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
AAPL 120.00 0.18%
More..
NASDAQ USA Top Gainers Stocks
CPSL 0.10 66.67%
LOCM 0.09 50.00%
GLBS 9.70 31.79%
LTRE 2.85 29.55%
ETRM 7.96 29.22%
INFI 2.00 29.03%
QKLS 0.14 27.27%
PRKR 2.57 26.60%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

NuVasive, Inc. (NASDAQ: NUVA)

NUVA Technical Analysis 5
As on 20th Jan 2017 NUVA Share Price closed @ 70.29 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 59.05 & Strong Buy for SHORT-TERM with Stoploss of 65.20 we also expect STOCK to react on Following IMPORTANT LEVELS.
NUVA Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
NUVA Other Details
Segment EQ
Market Capital 625492160.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.nuvasive.com
NUVA Address
NUVA
7475 Lusk Boulevard
San Diego, CA 92121
United States
Phone: 858-909-1800
Fax: 800-475-9134
NUVA Latest News
Interactive Technical Analysis Chart NuVasive, Inc. ( NUVA NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on NuVasive, Inc.
NUVA Business Profile
NuVasive, Inc. is a medical device company, that focuses on developing minimally disruptive surgical products and procedures for the spine. Its marketed product portfolio focused on applications for spine fusion surgery, including biologics. Its principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery (MAS), as well as offering of biologics, cervical and motion preservation products. spine surgery product line offerings, which include products for the thoracolumbar spine, the cervical spine, and a set of motion preservation product offerings under development, are primarily used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. Its biologic product line offerings include allograft, FormaGraft, a collagen synthetic product used to aid the fusion process, and Osteocel Plus, an allograft cellular matrix containing viable mesenchymal stem cells (MSCs), to aid in spinal fusion.